BRIEF — Saniona Says Data Reinforce SAN2465's Potential
Oct 13 (Reuters) — Saniona AB: Announces New Preclinical Data Reinforcing San2465's Potential As A Rapid-acting Antidepressant Preparing Investigational New Drug (Ind) Application To U.s. Food And Drug Administration, Expected To Be Submitted By End Of October San2465 Significantly Enhanced Hippocampal Synaptic Plastic